Vivus

Arena's Obese To-Do List
Motley Fool
Sat, 01/29/11 - 11:32 am
Arena Pharmaceuticals
Qnexa
Vivus
Rats Plague Arena's Diet Pill
Minyanville
Sat, 01/29/11 - 11:20 am
Arena Pharmaceuticals
Orexigen
obesity
diet drugs
Qnexa
Vivus
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Avanir
Discovery Labs
Cel-Sci
Vivus says FDA asks about Qnexa birth defect link
Yahoo/AP
Fri, 01/21/11 - 10:10 am
Qnexa
birth defects
FDA
Vivus
obesity
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
biotech
Cadence Pharmaceuticals
Cell Therapeutics
Enzon
Geron
Exelixis
Seattle Genetics
Savient
Vivus
Theravance
Vivus Says Erection Drug Works in 80 Percent of Men
Bloomberg
Thu, 01/13/11 - 01:35 pm
Vivus
erectile dysfunction
Avanafil
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
Vivus applies to market obesity drug Qnexa in EU
Marketwatch
Mon, 12/20/10 - 12:31 pm
Vivus
Qnexa
obesity
EU
Europe
ED Drug Could Support Vivus
Yahoo/Zacks.com
Thu, 12/9/10 - 12:22 pm
erectile dysfunction
Vivus
Pfizer
GSK
Avanafil
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
FDA
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Orexigen
options
Contrave
obesity
Vivus
Arena Pharmaceuticals
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
FDA
advisory panels
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Vivus narrows Q3 loss to $18M
Bizjournals.com
Mon, 11/8/10 - 05:24 pm
earnings
Vivus
Vivus sells Muse assets for $23.5M
Bizjournals.com
Mon, 11/8/10 - 10:51 am
M&A
Muse
Vivus
Meda
erectile dysfunction
FDA Ends October With Drug Approvals, Rejection
TheStreet.com
Mon, 11/1/10 - 08:59 am
FDA
Biodel
Avanir
Forest Labs
Arena Pharmaceuticals
Vivus
Amylin
Questcor Pharmaceuticals
Alkermes
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Sat, 10/30/10 - 12:14 pm
Vivus
Qnexa
obesity
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Fri, 10/29/10 - 11:49 am
Qnexa
FDA
obesity
Vivus
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Fri, 10/29/10 - 11:46 am
Vivus
Qnexa
obesity
diet pills
Arena Pharmaceuticals
FDA
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
Thu, 10/28/10 - 10:17 pm
FDA
diet drugs
Qnexa
Vivus
obesity

Pages